4 November 2024

Are you a researcher in the field of cancer therapies? Through its Demonstrator Projects, the Dutch Oncode Accelerator consortium provides grants for preclinical cancer therapy development. The first call for these projects is open until September 2025.

Innovating drug development

Discovering, developing and bringing new drugs to market is a lengthy, high-risk and expensive process. And new therapies are often only effective for some of the intended patients. The Dutch Oncode Accelerator consortium aims to address this problem by putting the patient first and innovating the preclinical phase of drug development. It is doing so through three innovation platforms: well-defined patient cohorts, artificially grown miniature organs and AI-based predictive models.

Demonstrator Projects

Oncode Accelerator is funding research through its Demonstrator Projects. These projects serve two goals: to develop potential therapies in the preclinical phase and to prove that the Oncode Accelerator infrastructure really does work. The targeted projects fall into four ‘workstreams’: small molecules, biologics, cell and gene therapy, and therapeutic vaccines.

Interested parties can now apply for a Demonstrator Project. For more information, see the Oncode Accelerator website.